On 4 March 2026, SIRNAOMICS-B (Stock Code: 02257) released its monthly return on movements in securities for the period ended 28 February 2026. The announcement shows that the authorised share capital remained unchanged at 230,000,000 ordinary shares, each with a par value of USD 0.001, bringing the total authorised capital to USD 230,000.
The company’s issued share capital remained at 107,221,538 shares, with no treasury shares. Public float stood at the threshold of 25%, indicating compliance with relevant requirements. No share issuance, repurchase, or changes to treasury shares were recorded during the month.
A total of 731,679 share options under the share option scheme remained outstanding at the end of February 2026, with no exercises, cancellations, or new grants taking place. Under the restricted share unit scheme, there were no new grants or issuances during the reporting period. No movements in warrants or convertible securities were reported.
Comments